Navigating the Medical Misinformation Age
When it comes to online health information, the Internet is a place where falsehoods flourish. Combating questionable content is no easy task, requiring education, legislation and diligence from stakeholders in the healthcare, scientific and public health communities.
Decatastrophizing Patient Fears
Your words, tone and body language can escalate patient fears, but they also have the power to ease anxiety and help patients cope.
Myths & Facts: GLP-1 Drugs for Weight Loss
Misconceptions about GLP-1 drugs could interfere with patients’ efforts to achieve their weight-loss goals.
Diagnosing and Treating Infant Botulism
Since the approval of BabyBIG, the only treatment for this rare but life-threatening disease affecting infants mostly under 6 months, the mortality rate is now less than 15 percent.
Update on Rabies
Though mostly eradicated in the U.S., treatment for rabies must begin immediately with hyperimmune globulin and vaccines.
New and Better Hemophilia A Treatment Options Just Keep Coming
With 16 FVIII products now approved for the treatment of hemophilia A, many patients with this disease are now able to live a normal life.
Diagnosing and Treating Lyme Disease
Lyme disease is a rare disease that can cause long-term damage thanks to delayed and missed diagnoses — but it may soon have a vaccine.
Myths & Facts: Kawasaki Disease
Educating physicians about this not-so-rare disease can curtail lifelong consequences that can occur if not diagnosed and treated early.
In the R&D Pipeline: New Agents to Prevent and Treat Hereditary Angioedema Attacks
A number of promising new agents in the R&D pipeline are likely to be approved in the very near future, expanding an already impressive range of treatment options — while further increasing the complexity of the HAE management decision process.
The Expanding Role of Immune Globulin Treatment in Diseases: Utilization and Growth
New research showing the therapeutic benefit of immune globulin for treating a variety of autoimmune diseases is contributing to market growth of this essential medicine.